Monika A Izano,Joan C Lo,Bruce Ettinger et al.
Monika A Izano et al.
Background: Few studies have examined factors that determine bisphosphonate (BP) continuation beyond 5 years in clinical practice. Objective: ...
Disease State Management [0.03%]
疾病状态管理
Ronald S Hadsall,Louise J Sargent
Ronald S Hadsall
OBJECTIVE: To explore how healthcare management has evolved from managing separate components to disease management. DATA SOURCES: Recent published atricles and the authors' experiences. STUDY SELECTION: Not applicable. DATA EXTRACTION: Not...
The Evolution of Disease State Management: Historical Milestones and Future Directions [0.03%]
疾病状态管理的发展历程：历史里程碑与未来方向
Laetitia A N&#x;Dri,Seojin Park,David B Nash et al.
Laetitia A N&#x;Dri et al.
Twenty-five years ago, the Journal of Managed Care Pharmacy introduced its readers to disease state management, which attempted to break the siloed culture of the U.S. health care system. Disease state management has been transformed, in pa...
Differences Between Managed Care and Fee-for-Service Medicaid in the Use of Generics for High-Rebate Drugs: The Cases of Insulin Glargine and Glatiramer [0.03%]
管理式护理与按服务收费的医疗补助在高回扣药物通用名药物使用上的差异：格拉泽胰岛素和醋酸格拉特默的例子
Inmaculada Hernandez,Walid F Gellad
Inmaculada Hernandez
Background: Statutory rebates and preferred drug lists (PDLs) may result in differential use of biosimilars and generics between Medicaid fee-for-service (FFS) and managed care organizations (MCOs), particularly for brand...
Projecting the Long-Term Economic Impact of Once-Monthly Paliperidone Palmitate Versus Oral Atypical Antipsychotics in Medicaid Patients with Schizophrenia [0.03%]
从经济学角度分析长效帕利哌酮与口服非典型抗精神病药物治疗医疗保险患者精神分裂症的长期效果
Antoine C El Khoury,Dominic Pilon,Laura Morrison et al.
Antoine C El Khoury et al.
Background: Recent evidence has demonstrated that, over 12 months, pharmacy costs associated with switching nonadherent recently relapsed patients from oral atypical antipsychotics (OAAs) to once-monthly paliperidone palm...
Cost-Effectiveness Analysis of Adjuvant Neratinib Following Trastuzumab in Early-Stage HER2-Positive Breast Cancer [0.03%]
曲妥珠单抗治疗后序贯奈拉替尼辅助治疗早期人表皮生长因子受体2过表达或突变阳性乳腺癌的成本效益分析
Phuong T Tran,Vakaramoko Diaby
Phuong T Tran
No funding supported the writing of this letter. The authors report no conflicts of interest related to the subject of this letter.
Risk Factors and Outcomes of Opioid Users with and Without Concurrent Benzodiazepine Use in the North Carolina Medicaid Population [0.03%]
北卡罗来纳州医疗补助项目中同时使用苯二氮卓类药物和阿片类药物患者的风险及预后研究
Anna Hung,Christopher Bush,Melissa Greiner et al.
Anna Hung et al.
Background: Concurrent use of opioids and benzodiazepines is associated with increased risk of opioid overdose and death. Clinical guidelines recommend against this practice and quality measures incentivize plans to minim...
Estimating HIV Management and Comorbidity Costs Among Aging HIV Patients in the United States: A Systematic Review [0.03%]
美国艾滋病患者管理与并发疾病的成本估算：一项系统回顾
Thomas Ward,Daniel Sugrue,Olivia Hayward et al.
Thomas Ward et al.
Background: As life expectancy of patients infected with human immunodeficiency virus (HIV) approaches that of the general population, the composition of HIV management costs is likely to change. ...
Direct Costs Incurred Among Women Undergoing Surgical Procedures to Treat Uterine Fibroids [0.03%]
接受手术治疗子宫肌瘤妇女的直接费用支出
Amanda Harrington,Nicole G Bonine,Erika Banks et al.
Amanda Harrington et al.
Background: Uterine fibroids (UF) affect up to 70%-80% of women by 50 years of age and represent a substantial economic burden on patients and society. Despite the high costs associated with UF, recent studies on the cost...
Estimating the Effect of a National Pharmacy-Led Influenza Vaccination Voucher Program on Morbidity, Mortality, and Costs [0.03%]
全国药店主导的流感疫苗代金券计划对疾病负担、死亡率和成本的影响评估
Tanya Singh,Michael Taitel,Dorothy Loy et al.
Tanya Singh et al.
Background: Influenza (also known as "flu") is estimated to cause between 12,000 and 79,000 deaths annually. Vaccinations are beneficial in preventing influenza cases and reducing the likelihood of severe outcomes. Unfort...